AR015218A1 - Procedimiento para la preparacion de (-) cis-3-hidroxi-1-metil-4-(2,4,6-trimetoxifenil)-piperidina, un compuesto para su uso exclusivo en dicho procedimiento. - Google Patents

Procedimiento para la preparacion de (-) cis-3-hidroxi-1-metil-4-(2,4,6-trimetoxifenil)-piperidina, un compuesto para su uso exclusivo en dicho procedimiento.

Info

Publication number
AR015218A1
AR015218A1 ARP990100242A ARP990100242A AR015218A1 AR 015218 A1 AR015218 A1 AR 015218A1 AR P990100242 A ARP990100242 A AR P990100242A AR P990100242 A ARP990100242 A AR P990100242A AR 015218 A1 AR015218 A1 AR 015218A1
Authority
AR
Argentina
Prior art keywords
methyl
hydrobromide
water
trimethoxyphenyl
piperidin
Prior art date
Application number
ARP990100242A
Other languages
English (en)
Spanish (es)
Original Assignee
Gompel Marie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gompel Marie filed Critical Gompel Marie
Publication of AR015218A1 publication Critical patent/AR015218A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP990100242A 1998-01-23 1999-01-21 Procedimiento para la preparacion de (-) cis-3-hidroxi-1-metil-4-(2,4,6-trimetoxifenil)-piperidina, un compuesto para su uso exclusivo en dicho procedimiento. AR015218A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19802449A DE19802449A1 (de) 1998-01-23 1998-01-23 Verfahren zur Herstellung von (-)cis-3-Hydroxy-1-methyl-4-(2,4,6-trimethoxypyhenyl)-piperidin

Publications (1)

Publication Number Publication Date
AR015218A1 true AR015218A1 (es) 2001-04-18

Family

ID=7855418

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990100242A AR015218A1 (es) 1998-01-23 1999-01-21 Procedimiento para la preparacion de (-) cis-3-hidroxi-1-metil-4-(2,4,6-trimetoxifenil)-piperidina, un compuesto para su uso exclusivo en dicho procedimiento.

Country Status (26)

Country Link
US (1) US6225473B1 (enExample)
EP (1) EP1049674B1 (enExample)
JP (1) JP4585116B2 (enExample)
KR (1) KR100567941B1 (enExample)
CN (1) CN1137096C (enExample)
AR (1) AR015218A1 (enExample)
AT (1) ATE355270T1 (enExample)
AU (1) AU762407B2 (enExample)
BR (1) BR9814774B1 (enExample)
CA (1) CA2318946C (enExample)
CY (1) CY1106511T1 (enExample)
CZ (1) CZ298852B6 (enExample)
DE (2) DE19802449A1 (enExample)
DK (1) DK1049674T3 (enExample)
ES (1) ES2281943T3 (enExample)
HU (1) HU227928B1 (enExample)
IL (1) IL137422A (enExample)
NO (1) NO321933B1 (enExample)
NZ (1) NZ505897A (enExample)
PL (1) PL190790B1 (enExample)
PT (1) PT1049674E (enExample)
RU (1) RU2265595C2 (enExample)
SK (1) SK285883B6 (enExample)
TR (1) TR200002146T2 (enExample)
WO (1) WO1999037615A1 (enExample)
ZA (1) ZA99477B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6437136B2 (en) * 1998-01-23 2002-08-20 Aventis Pharma Deutschland Gmbh Process for the preparation of (−)cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)piperidine
DE19809649A1 (de) * 1998-03-06 1999-09-09 Hoechst Marion Roussel De Gmbh Verfahren zur enzymatischen Enantiomeren-Trennung von 3(R)- und 3(S)-Hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)-1,2,3,6-tetrahydro-pyridin bzw. der Carbonsäureester
JP6851978B2 (ja) 2015-04-20 2021-03-31 スミトモ ダイニッポン ファーマ オンコロジー， インコーポレイテッド ミトコンドリアプロファイリングによるアルボシジブ応答の予測
WO2016187316A1 (en) 2015-05-18 2016-11-24 Tolero Pharmaceuticals, Inc. Alvocidib prodrugs having increased bioavailability
BR112018002427A8 (pt) 2015-08-03 2022-10-18 Tolero Pharmaceuticals Inc Uso de alvocidib e de azacitidina ou decitabina para tratar câncer e kit e composição farmacêutica contendo as ditas substâncias
US11279694B2 (en) 2016-11-18 2022-03-22 Sumitomo Dainippon Pharma Oncology, Inc. Alvocidib prodrugs and their use as protein kinase inhibitors
EP3362471B1 (en) 2016-12-19 2021-11-17 Sumitomo Dainippon Pharma Oncology, Inc. Profiling peptides and methods for sensitivity profiling
US11497756B2 (en) 2017-09-12 2022-11-15 Sumitomo Pharma Oncology, Inc. Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1 inhibitor alvocidib
US11034710B2 (en) 2018-12-04 2021-06-15 Sumitomo Dainippon Pharma Oncology, Inc. CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
WO2020191326A1 (en) 2019-03-20 2020-09-24 Sumitomo Dainippon Pharma Oncology, Inc. Treatment of acute myeloid leukemia (aml) with venetoclax failure
CN110577974B (zh) * 2019-09-10 2021-07-20 杭州澳赛诺生物科技有限公司 手性3-羟基-1,2,3,6-四氢吡啶的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN164232B (enExample) * 1986-04-11 1989-02-04 Hoechst India
DE3836676A1 (de) * 1988-10-28 1990-05-03 Hoechst Ag Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel
US5284856A (en) * 1988-10-28 1994-02-08 Hoechst Aktiengesellschaft Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives
US5849733A (en) * 1996-05-10 1998-12-15 Bristol-Myers Squibb Co. 2-thio or 2-oxo flavopiridol analogs
US5908934A (en) * 1996-09-26 1999-06-01 Bristol-Myers Squibb Company Process for the preparation of chiral ketone intermediates useful for the preparation of flavopiridol and analogs

Also Published As

Publication number Publication date
JP4585116B2 (ja) 2010-11-24
KR20010024867A (ko) 2001-03-26
WO1999037615A1 (de) 1999-07-29
ZA99477B (en) 1999-09-23
SK10972000A3 (sk) 2000-12-11
PL342064A1 (en) 2001-05-21
CZ20002665A3 (cs) 2001-11-14
BR9814774B1 (pt) 2010-10-05
IL137422A0 (en) 2001-07-24
KR100567941B1 (ko) 2006-04-07
PT1049674E (pt) 2007-04-30
DE19802449A1 (de) 1999-07-29
TR200002146T2 (tr) 2000-12-21
CN1284065A (zh) 2001-02-14
SK285883B6 (sk) 2007-10-04
SK285883B9 (enExample) 2007-12-06
ATE355270T1 (de) 2006-03-15
US6225473B1 (en) 2001-05-01
CA2318946A1 (en) 1999-07-29
HK1033319A1 (en) 2001-08-24
CY1106511T1 (el) 2012-01-25
JP2002501048A (ja) 2002-01-15
EP1049674B1 (de) 2007-02-28
RU2265595C2 (ru) 2005-12-10
CZ298852B6 (cs) 2008-02-27
ES2281943T3 (es) 2007-10-01
AU2513599A (en) 1999-08-09
CN1137096C (zh) 2004-02-04
IL137422A (en) 2005-11-20
AU762407B2 (en) 2003-06-26
NO20003454L (no) 2000-07-04
NO20003454D0 (no) 2000-07-04
EP1049674A1 (de) 2000-11-08
HUP0100649A1 (hu) 2001-07-30
NO321933B1 (no) 2006-07-24
BR9814774A (pt) 2000-11-14
HU227928B1 (en) 2012-06-28
NZ505897A (en) 2003-03-28
DE59813924D1 (de) 2007-04-12
HUP0100649A3 (en) 2002-12-28
PL190790B1 (pl) 2006-01-31
CA2318946C (en) 2009-11-03
DK1049674T3 (da) 2007-06-25

Similar Documents

Publication Publication Date Title
AR015218A1 (es) Procedimiento para la preparacion de (-) cis-3-hidroxi-1-metil-4-(2,4,6-trimetoxifenil)-piperidina, un compuesto para su uso exclusivo en dicho procedimiento.
FI84557B (fi) Foerfarande foer isolering och rening av podofyllotoxin.
IE870497L (en) Tetrahydropyridin-3-carboxaldehyde oxime
CA1163993A (en) Process for the manufacture of an oxo compound and new intermediates required therefor
AR013051A1 (es) Aislacion y purificacion de esteroles a partir de fracciones neutras de resina de tallol mediante cristalizacion de decantacion unica
DE2741233A1 (de) Verfahren zur herstellung von methoxypsoralen
Kálai et al. Synthesis of pyrroline nitroxide annulated carbocycles and heterocycles
RU2000122151A (ru) Способ получения (-)-цис-3-гидрокси-1-метил-4-(2,4,6-триметоксифенил) пиперидина
ES2213991T3 (es) Procedimiento de preparacion de derivados de la 4-fenil-1,2,3,6-tetrahidropiridina y productos intermedios empleados.
Escudero et al. [4+ 2] Cycloadditions between 2-pyrones and benzyne. Application to the synthesis of binaphthyls
Puodziunaite et al. Bromination of aromatic ring of tetrahydro-1, 5-benzodiazepin-2-ones
Cava et al. Condensed Cyclobutane Aromatic Compounds. XXVIII. α-Bromo Derivatives of Benzocyclobutenone
Popaj et al. Syntheses of the Macrocyclic Spermine Alkaloids (±)‐Budmunchiamine A–C
Zolfigol et al. 1, 4-Diazabicyclo [2.2. 2] octane 1, 4-Bis (oxide)-Bis (hydrogen peroxide)/MCl x as a Novel Heterogeneous System for the Oxidation of Urazoles under Mild Conditions
Clark et al. Alkaloids of the amaryllidaceae: Brunsvigine: NMR, ORD/CD and mass spectrometry, degradation and interconversion studies
RU2003100505A (ru) Способ получения производных хинолина
Sparatore et al. Epimerization of lupinine to epilupinine and vice versa. Reexamination of the structures of lupinal and epilupinal
Gu et al. Efficient Synthetic Route to Carbopyronine Fluorenscent Dye Intermediate
Bishop et al. The behaviour of unsaturated 1, 2-hydroxyiminoketones with trifluoroacetic acid
US6762327B2 (en) Selective oxidation process with enhanced safety
US5132436A (en) Intermediates for making 14-crown-4-ether derivatives
Santhosh et al. Synthesis of Pterocarpans by Means of a “Disfavored” 5‐endo‐trig Radical Cyclization Reaction
Sabitha et al. Trimethylsilyl Iodide‐Promoted Aza‐Prins Cyclization for the Synthesis of 4‐Iodopiperidines
EP0003484B1 (de) Verfahren zur Herstellung von Chromanderivaten
CN1041627C (zh) (s)－2,2,2－三氯－n－(2－氯环己－2－烯基)－乙酰胺和(s)－2－氯环己－2－烯胺

Legal Events

Date Code Title Description
FG Grant, registration